News tagged with lancet oncology
Related topics: breast cancer , cancer
Gene test could solve prostate cancer riddle and spare thousands from surgery
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology.
Feb 09, 2011 |
not rated yet |
0
Scientist leads successful drug trial for childhood leukaemia
(PhysOrg.com) -- Research has shown that a new cancer treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.
Dec 21, 2010 |
5 / 5 (1) |
0
Long-lasting benefit of radiotherapy for localized breast cancer confirmed in study
A study confirms the long-lasting benefit of radiotherapy for localized breast cancer, and reports importance of tamoxifen for reducing recurrence.
Dec 10, 2010 |
not rated yet |
0
Largest-ever breast cancer surgery study published
A less invasive surgical procedure for detecting breast cancer spread has for the first time been proven to achieve the same cancer survival and recurrence control as traditional lymph node removal surgery in patients whose ...
Sep 22, 2010 |
not rated yet |
0
Less intensive drug schedule as effective as standard treatment for blood cancer
A less intensive bortezomib-based regimen (given once instead of twice per week) followed by maintenance therapy, is as effective as the standard treatment for elderly patients with multiple myeloma, but with fewer serious ...
Aug 23, 2010 |
not rated yet |
0
Duke scientist's cancer research is questioned
(AP) -- Concerns are being raised about the validity of research done by a Duke University cancer scientist who recently was placed on leave while the school investigates whether he falsely claimed to be a Rhodes scholar.
Jul 23, 2010 |
not rated yet |
0
Bevacizumab is safe in combination with chemotherapy for advanced non-squamous non-small cell lung cancer
Researchers have confirmed the safety of treating advanced non-squamous non-small-cell lung cancer with bevacizumab in combination with chemotherapy. Crucially, this study, published Online First in The Lancet Oncology, did no ...
Jul 19, 2010 |
5 / 5 (1) |
2
14-year trial shows that prostate cancer screening reduces deaths by almost half
or clues such as pre-cancerous cells - is strongly encouraged as a way of improving public health. However, there are doubts as to whether the benefits of screening outweighs the negatives. Over-diagnosis is one of the biggest ...
Jun 30, 2010 |
4 / 5 (5) |
0
Excess weight linked to increased risk of dying from cancer in populations of Asia-Pacific
Overweight and obese individuals from the Asia-Pacific region are significantly more likely to die from cancer compared with individuals in the normal weight range. New strategies are urgently needed to tackle the obesity ...
Jun 29, 2010 |
not rated yet |
0
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according ...
Jun 05, 2010 |
not rated yet |
0
Bone drug suppresses wandering tumor cells in breast cancer patients
The bone-strengthening drug zoledronic acid (Zometa) can help fight metastatic breast cancer when given before surgery, suggests research at Washington University School of Medicine in St. Louis.
Jun 02, 2010 |
not rated yet |
0
Smarter use of existing treatment helps dramatically boost survival of young AML patients
More individualized therapy and better supportive care helped push the survival for children with acute myeloid leukemia (AML) to 71 percent three years after diagnosis, according to new research led by St. Jude Children's ...
May 10, 2010 |
not rated yet |
0
No difference in survival between leukaemia patients 10 years after undergoing stem-cell or marrow transplant
Patients transplanted with peripheral blood stem cells (PBSC) have no difference in survival compared with patients given bone marrow after 10 years, according to the largest randomised study comparing the effect of type ...
Jan 31, 2010 |
not rated yet |
0
HPV testing prevents more invasive cervical cancers than cytology
Human papillomavirus (HPV) DNA testing prevents more invasive cervical cancer compared to cytology screening alone by detecting persistent high-grade lesions (which lead to cervical cancer) at an earlier time. As such, HPV ...
Jan 18, 2010 |
not rated yet |
0
Gefitinib improves survival compared with standard chemotherapy in lung cancer patients with genetic mutation
Patients with the most common form of lung cancer (non-small-cell lung cancer) who have mutations in the epidermal growth factor receptor (EGFR) gene have significantly improved progression-free survival if they are treated ...
Dec 20, 2009 |
4.3 / 5 (3) |
0
